Inter Pharma PCL (BKK:IP)
Thailand flag Thailand · Delayed Price · Currency is THB
3.920
+0.020 (0.51%)
At close: Mar 13, 2026

Inter Pharma PCL Cash Flow Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
122.3836.6550.79118.88105.22
Depreciation & Amortization
112.66109.5397.1864.4725.67
Other Amortization
4.093.051.071.280.93
Loss (Gain) From Sale of Assets
1.071.080.470.833.6
Asset Writedown & Restructuring Costs
0.820.133.05--
Loss (Gain) From Sale of Investments
8.968.143.895.171.8
Loss (Gain) on Equity Investments
1.231.592.270.770.08
Provision & Write-off of Bad Debts
-2.77----
Other Operating Activities
56.631.6522.4431.6516.21
Change in Accounts Receivable
-15.63-15.63-43.82-43.02-138.36
Change in Inventory
-31.720.79-24.4-60.61-85.31
Change in Accounts Payable
53.24-15.8810.1526.3235.21
Change in Other Net Operating Assets
-3.05-3.25-1.68-2.63-6.62
Operating Cash Flow
307.88177.84121.42143.09-41.57
Operating Cash Flow Growth
73.13%46.46%-15.14%--
Capital Expenditures
-140.56-237.43-106.46-27.37-224.15
Sale of Property, Plant & Equipment
2.391.540.050.252.8
Cash Acquisitions
-1.9-95.18--538.45-106.57
Sale (Purchase) of Intangibles
-23.13-24.03-37.63-22.6-13.69
Investment in Securities
-0.08-0.07-36.32-0.02-10.23
Other Investing Activities
-7.2145.16-52.40.060.06
Investing Cash Flow
-170.49-310.01-232.77-588.13-351.79
Short-Term Debt Issued
41.2239.184520120
Long-Term Debt Issued
29.8-6200139
Total Debt Issued
71.0239.1851220259
Short-Term Debt Repaid
-1.8-5.4-47.6-112.06-
Long-Term Debt Repaid
-96.17-96.64-171.43-79.68-23.19
Total Debt Repaid
-97.97-102.04-219.03-191.74-23.19
Net Debt Issued (Repaid)
-26.95-62.86-168.0328.26235.81
Issuance of Common Stock
0--1,043192.22
Common Dividends Paid
--12.97-67--4.83
Other Financing Activities
-14.31-19.62-17.83-23.55-8.28
Financing Cash Flow
-41.26-95.45-252.861,048414.92
Foreign Exchange Rate Adjustments
-0.1-0.170.17-0.26-0.01
Net Cash Flow
96.04-227.79-364.03602.5621.54
Free Cash Flow
167.33-59.5914.96115.72-265.73
Free Cash Flow Growth
---87.07%--
Free Cash Flow Margin
7.56%-3.12%0.83%7.54%-28.85%
Free Cash Flow Per Share
0.28-0.100.030.22-0.56
Cash Interest Paid
18.8419.6224.0323.057.67
Cash Income Tax Paid
28.7816.4846.7331.5631.08
Levered Free Cash Flow
91.71-96.13-52.3739.75-317.63
Unlevered Free Cash Flow
103.95-83.72-36.2754.33-312.62
Change in Working Capital
2.86-13.97-59.75-79.95-195.09
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.